Helixmith has been granted a patent for a pharmaceutical composition to treat ADHD. The composition includes a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber. This innovative treatment inhibits glutamate receptors, alleviates symptoms, and improves fMRI results in child patients. GlobalData’s report on Helixmith gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Helixmith, Viral vectors was a key innovation area identified from patents. Helixmith's grant share as of May 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents.
Pharmaceutical composition for treating adhd
A recently granted patent (Publication Number: US11975039B2) discloses a pharmaceutical composition designed for the treatment of attention deficit hyperactivity disorder (ADHD). The composition includes a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber as the active ingredient, along with a pharmaceutically acceptable carrier. The extract can be obtained through extraction with organic solvents, water, or a combination of both, with specific examples of organic solvents provided in the claims.
Furthermore, the patent also covers a food composition aimed at alleviating ADHD symptoms, containing the same mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber. Additionally, a method for alleviating or treating ADHD is outlined, involving the administration of the aforementioned composition to individuals suffering from the disorder. The method may also include the administration of methylphenidate along with the composition for enhanced efficacy in managing ADHD symptoms.
To know more about GlobalData’s detailed insights on Helixmith, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
